Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Fasting on Disease Activity and the Gut Microbiota in Patients With Psoriasis and Psoriatic Arthritis - the RiseFast Pilot Study

NCT06905028 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT06905028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06905028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Fasting on Disease Activity and the Gut Microbiota in Patients With Psoriasis and Psoriatic Arthritis - the RiseFast Pilot Study
Lead sponsor
Charite University, Berlin, Germany
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 4, 2025
Completion date
September 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis (pso), psoriasis arthritis